George Wallace has over 40 years of medical device experience in marketing, sales, and general management.
He has organized, financed, and built multiple medical device companies through IPO and acquisition, including several in the cardiovascular & neurovascular fields.
George has served on the board of directors for many innovative start-up companies. Prior to founding EnCompass Technologies, Inc., George founded and spent 15+ years at
Intersect Partners LLC–a medical device incubator conducting research and development for medical device solutions to large and unmet medical needs.
Mike Jones has over 35 years of medical device experience in product development, manufacturing, & delivering products to the market. His experience
includes 5+ cardiovascular and neurovascular companies. Mike currently holds over 100 medical device patents. Prior to founding EnCompass
Technologies, Inc., he consulted in the medical device industry for 20 years with expertise in product design & development, prototyping, patent
assessment, materials selection & processing, balloon development, and more. A few key clients included Edwards Lifescience Inc., SenoRx Inc., Vascular
Control Systems Inc., and Fallbrook Engineering. Mike holds an MS in Engineering from CSU Long Beach and a BA in Chemical Engineering from UC
Mary Lou has over 35 years of experience and has successfully guided six startups through US regulatory approvals. Prior to joining
EnCompass Technologies, she served as the Vice President of Regulatory, Clinical & Quality at five startup companies: FRESCA Medical,
Reshape Medical, USGI Medical, SenoRx and Focal. Her regulatory and clinical experience spans multiple therapeutic areas including
cardiovascular, gastroenterology, respiratory and women’s health. Mary Lou has designed and successfully executed numerous clinical studies
and secured PMA approvals, de novo requests and 510(k) clearances. From 2001 to 2005, she served as the industry representative on the
FDA Obstetrics and Gynecology Devices Advisory Panel. Mary Lou holds an MS in Biomedical Science from Drexel University and a BA in
Biology from La Salle University.
Francis is an accomplished heart surgeon (23 years), corporate executive (16 years), venture capitalist (6 years), and entrepreneur (6 years).
Board-certified in General (UCSF) and Cardiothoracic Surgery (Duke Univ), his seminal work advanced the new field of minimally invasive cardiac
surgery and led to 32 patents for surgical devices used in hundreds of thousands of heart operations worldwide.
At Edwards Lifesciences, Francis served as the General Manager of Ascendra Transcatheter Heart Valve Therapy and
later Chief Medical Officer, where he led Medical, Clinical, and Regulatory Affairs, and Health Economics/Reimbursement.
In 2018, he co-founded Koa Accel, a medical device accelerator based in Orange County, which has spun-out three companies.
May 23, 2023
World's First Use of EnCompass Medical Device to Protect Against Brain Injury Achieved at the
Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia